If you look at (avxl) anavex their alzhiemers medicine 2-73 isn't any more promising than bapi or ponezumab, and they are trading at .25 cents ilns has bigger and more promising pipeline in my opinion
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.